🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2007-07
Trial ID
NCT00506831
Treatments Being Tested
The objective of the present study is to evaluate the activity and safety o...
Status
Completed
Location
University of Heidelberg, Mannheim University Medical Center
Start Date
2010-06
Trial ID
NCT01137916
Treatments Being Tested
the primary objective of this study is to assess the efficacy (progression-...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-11-25
Trial ID
NCT04633122
Treatments Being Tested
Primary Objective: 1\. To assess the safety and toxicity of imatinib mesyl...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2003-08
Trial ID
NCT00386373
Treatments Being Tested
An open label randomised trial for adults with histologically confirmed mea...
Status
Unknown
Location
Canberra Hospital
Start Date
2015-06-30
Trial ID
NCT02365441
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2004-01
Trial ID
NCT00244829
Treatments Being Tested
The purpose of this trial is to assess the effect of switching CML patients...
Status
Terminated
Location
Aarhus University Hospital
Start Date
2013-04
Trial ID
NCT01866553
Treatments Being Tested
The most common sites for GIST to occur are the stomach (60-70%) and proxim...
Status
Terminated
Location
Radboudumc
Start Date
2014-08
Trial ID
NCT02185937
Treatments Being Tested
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
In this phase I study, the investigators will determine the maximum tolerat...
Status
Completed
Location
Tennessee Oncology, PLLC
Start Date
2004-07
Trial ID
NCT00611689
Treatments Being Tested